1. Low-dose triple drug combination targeting the PI3K/AKT/mTOR pathway and the MAPK pathway is an effective approach in ovarian clear cell carcinoma

   Caumanns, J. J., van Wijngaarden, A., Kol, A., Meersma, G. J., Jalving, M., Bernards, R., van der Zee, A. G. J., Wisman, G. B. A. & de Jong, S., 2019, In : Cancer letters. 461, p. 102-111 10 p.

   Research output: Contribution to journal › Article › Academic › peer-review

2. DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort

   van Leeuwen, R. W., Ostrbenk, A., Poljak, M., van der Zee, A. G. J., Schuuring, E. & Wisman, G. B. A., 15-Feb-2019, In : International Journal of Cancer. 144, 4, p. 746-754 9 p.

   Research output: Contribution to journal › Article › Academic › peer-review

3. Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer

   Verlaat, W., van Leeuwen, R. W., Novianti, P. W., Schuuring, E., Meijer, C. J. L. M., van der Zee, A. G. J., Snijders, P. J. F., Heideman, D. A. M., Steenbergen, R. D. M. & Wisman, G. B. A., 25-Aug-2018, In : Epigenetics. 13, 7, p. 769-778 11 p.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Integrated transcriptomic and epigenomic analysis of ovarian cancer reveals epigenetically silenced GULP1

   Maldonado, L., Brait, M., Izumchenko, E., Begum, S., Chatterjee, A., Sen, T., Loyo, M., Barbosa, A., Poeta, M. L., Makarev, E., Zhavoronkov, A., Fazio, V. M., Angioli, R., Rabitti, C., Ongenaert, M., Van Criekinge, W., Noordhuis, M. G., de Graeff, P., Wisman, G. B. A., van der Zee, A. G. J. & Hoque, M. O., 1-Oct-2018, In : Cancer letters. 433, p. 242-251 10 p.

   Research output: Contribution to journal › Article › Academic › peer-review

5. HER2 immunohistochemistry in endometrial and ovarian clear cell carcinoma: discordance between antibodies and with in-situ hybridisation

   Koopman, T., van der Vegt, B., Dijkstra, M., Bart, J., Duiker, E., Wisman, G. B. A., de Bock, G. H. & Hollema, H., Nov-2018, In : Histopathology. 73, 5, p. 852-863 12 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (73) »

1. Dataset: Inter-laboratory agreement of the Cervista HPV HR test with a second cut-off at default setting of 1.93 (A) and at new setting of 5.0 (B)

   Boers, A. (Creator), Slagter-Menkema, L. (Creator), Hemel, van, B. (Creator), Belinson, J. L. (Creator), Ruitenbeek, T. (Creator), Buikema, H. (Creator), Klip, H. (Creator), Ghyssaert, H. (Creator), Zee, van der, A. (Creator), Bock, de, T. (Creator), Schuurs-Wisman, B. (Creator), Schuuring, E. (Creator), University of Groningen, 22-Jul-2014

   DOI: https://doi.org/10.1371/journal.pone.0101930.t006

   Dataset

View all (1) »

1. Cervical cancer screening in the Netherlands: What can be improved?

   G.B.A. Wisman (Invited speaker)

   20-Mar-2015

   Activity: Talk or presentation › Professional

2. The identification of genes regulated by methylation linked to platinum resistance in HGSOC

   G.B.A. Wisman (Invited speaker)

   24-Nov-2015

   Activity: Talk or presentation › Professional

3. EurOPDX consortium (External organisation)

   G.B.A. Wisman (Member)

   2014 → …

   Activity: Membership › Membership of network › Academic

View all (6) »

1. UMCG krijgt vier ton subsidie voor verbetering onderzoek naar baarmoederhalskanker.

   Bea Schuurs-Wisman

   27/06/2019

   1 Media contribution

   Press/Media: Expert Comment › Popular

2. UMCG krijgt vier ton subsidie voor verbetering onderzoek naar baarmoederhalskanker.

   Bea Schuurs-Wisman, Ed Schuuring & Truuske Bock, de

   27/06/2019

   2 Media contributions

   Press/Media: Research › Popular

View all (2) »